Mercer Global Advisors Inc. ADV purchased a new stake in Agilent Technologies Inc (NYSE:A) in the 1st quarter, HoldingsChannel reports. The fund purchased 13,028 shares of the medical research company’s stock, valued at approximately $879,000.
Several other large investors have also recently modified their holdings of A. IFM Investors Pty Ltd lifted its position in Agilent Technologies by 9.4% in the 4th quarter. IFM Investors Pty Ltd now owns 18,362 shares of the medical research company’s stock worth $1,239,000 after buying an additional 1,574 shares in the last quarter. BTIM Corp. increased its stake in shares of Agilent Technologies by 21.9% during the 4th quarter. BTIM Corp. now owns 58,267 shares of the medical research company’s stock worth $3,931,000 after purchasing an additional 10,475 shares during the last quarter. Fulton Bank N.A. increased its stake in shares of Agilent Technologies by 8.6% during the 4th quarter. Fulton Bank N.A. now owns 4,587 shares of the medical research company’s stock worth $309,000 after purchasing an additional 362 shares during the last quarter. Standard Life Aberdeen plc increased its stake in shares of Agilent Technologies by 13.2% during the 3rd quarter. Standard Life Aberdeen plc now owns 85,030 shares of the medical research company’s stock worth $5,998,000 after purchasing an additional 9,889 shares during the last quarter. Finally, Nordea Investment Management AB increased its stake in shares of Agilent Technologies by 17.7% during the 3rd quarter. Nordea Investment Management AB now owns 18,394 shares of the medical research company’s stock worth $1,298,000 after purchasing an additional 2,760 shares during the last quarter.
In related news, VP Mark Doak sold 16,421 shares of Agilent Technologies stock in a transaction dated Friday, February 22nd. The shares were sold at an average price of $77.95, for a total transaction of $1,280,016.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Michael Tang sold 6,728 shares of Agilent Technologies stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total transaction of $541,604.00. The disclosure for this sale can be found here. Insiders have sold a total of 83,722 shares of company stock valued at $6,532,504 over the last ninety days.
Shares of Agilent Technologies stock opened at $77.55 on Wednesday. The company has a quick ratio of 2.79, a current ratio of 3.39 and a debt-to-equity ratio of 0.36. Agilent Technologies Inc has a fifty-two week low of $60.42 and a fifty-two week high of $82.27. The firm has a market capitalization of $25.53 billion, a price-to-earnings ratio of 27.80, a P/E/G ratio of 2.23 and a beta of 1.38.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 20th. The medical research company reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.73 by $0.03. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. Agilent Technologies had a net margin of 22.86% and a return on equity of 19.90%. The business’s revenue was up 6.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.66 EPS. On average, equities research analysts expect that Agilent Technologies Inc will post 3.06 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd will be issued a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.85%. The ex-dividend date is Monday, April 1st. Agilent Technologies’s payout ratio is 23.66%.
TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2019/04/17/13028-shares-in-agilent-technologies-inc-a-acquired-by-mercer-global-advisors-inc-adv.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.